The 12 analysts offering 12-month price forecasts for MorphoSys AG have a median target of 13.78, with a high estimate of 35.01 and a low estimate of 11.29. The median estimate represents a +74.90% increase from the last price of 7.88.
The current consensus among 13 polled investment analysts is to Buy stock in MorphoSys AG. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$1.09
Reporting Date Mar 17
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.